Senti Biosciences Inc.

NASDAQ: SNTI · Real-Time Price · USD
1.56
0.04 (2.63%)
At close: Aug 18, 2025, 2:45 PM

Senti Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-52.79M -71.06M -58.22M -55.32M
Depreciation & Amortization
5.85M 5.43M 3.92M 3.01M
Stock-Based Compensation
1.75M 9.67M 16.39M 2.29M
Other Working Capital
3.31M 4.45M 13.85M 1.83M
Other Non-Cash Items
-256K -1.1M -10.89M 14.74M
Deferred Income Tax
n/a n/a n/a 22K
Change in Working Capital
4.04M 4.67M 13.9M 615K
Operating Cash Flow
-41.4M -52.4M -34.9M -34.63M
Capital Expenditures
-26K -12.04M -41.37M -5.54M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a -17.99M -40.59M n/a
Sales Maturities Of Investments
n/a 60M n/a n/a
Other Investing Acitivies
60K 105K -40.59M n/a
Investing Cash Flow
34K 30.08M -81.96M -5.54M
Debt Repayment
n/a -108K 5.17M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.9M 375K 112.65M 1.48M
Financial Cash Flow
53.73M 779K 118.55M 68.44M
Net Cash Flow
12.37M -21.54M 1.7M 28.26M
Free Cash Flow
-41.42M -64.43M -76.27M -40.18M